Table 1.
Expression of TLR4 in CINs and ISCCs
| Tissues | Degree of immunoreactivity (%) | |||
|---|---|---|---|---|
| – | 1+ | 2+ | 3+ | |
| Normala | 8/50 (16.0) | 17/50 (34.0) | 13/50 (26.0) | 12/50 (24.0) |
| CIN Ib | 15/49 (30.6) | 18/49 (36.7) | 10/49 (20.4) | 6/49 (12.2) |
| CIN IIc | 21/32 (65.6) | 9/32 (28.1) | 2/32 (6.3) | 0/32 (0.0) |
| CIN IIId | 20/23 (87.0) | 3/23 (13.0) | 0/23(0.0) | 0/23 (0.0) |
| ISCCse | 23/26 (88.5) | 3/26 (11.5) | 0/26 (0.0) | 0/26 (0.0) |
CIN cervical intraepithelial neoplasia, ISCCs invasive squamous cell carcinomas
a–b P > 0.005, a–c P < 0.005, a–d P < 0.005, a–e P < 0.005, b–c P < 0.005, b–d P < 0.005, b–e P < 0.005, c–d P > 0.005, c–e P > 0.005, and d–e P > 0.005